News
Medical meetings may be forever changed
Is it a silver lining to the coronavirus pandemic?
News
FDA OKs new drug for triple-negative breast cancer
Sacituzumab govitecan-hziy (Trodelvy) is now approved for adults with metastatic triple-negative breast cancer who received at least two prior...
News
ASCO announces its own COVID-19 and cancer registry
ASCO aims to learn how COVID-19 is impacting cancer patients’ treatment and outcomes.
News
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
News
First advance in MDS for decade: Luspatercept for anemia
Luspatercept has been approved by the FDA to treat anemia in patients with myelodysplastic syndromes.
News
Doctors sound off about future of medical meetings
Is it a silver lining to the coronavirus pandemic?
News
‘Like a coin flip’: Assay denies some cancer patients new drug
Investigators find fault with an assay used to determine which triple-negative breast cancer patients are eligible to receive atezolizumab.
